Related Experiment Video
Updated: Jul 19, 2025

08:09
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
9.6K
DL-TCNN: Deep Learning-based Temporal Convolutional Neural Network for prediction of conformational B-cell epitopes
Pratik Angaitkar1, Rekh Ram Janghel1, Tirath Prasad Sahu1
1Department of Information Technology, National Institute of Technology, Raipur, G.E. Road, Raipur, C.G. 492010 India.
3 Biotech
|August 14, 2023
Summary
A new Deep Learning-based Temporal Convolutional Neural Network (DL-TCNN) model accurately predicts conformational B-cell epitopes (CBCE). This advanced framework offers improved accuracy for vaccine design and drug discovery.
Area of Science:
- Immunoinformatics
- Computational Biology
- Machine Learning in Medicine
Background:
- Predicting conformational B-cell epitopes (CBCE) is crucial for vaccine design, drug development, and disease diagnosis.
- Traditional laboratory methods are time-consuming and expensive, driving the adoption of computational approaches like Machine Learning (ML).
- Existing ML methods face challenges in achieving high accuracy for CBCE prediction.
Purpose of the Study:
- To introduce a novel Deep Learning-based Temporal Convolutional Neural Network (DL-TCNN) framework for enhanced CBCE prediction.
- To leverage the strengths of deep learning, specifically hybridizing 1D-CNN and TCN architectures, for improved predictive performance.
- To address limitations in existing ML models and improve the accuracy of CBCE prediction.
Main Methods:
- Physicochemical features were extracted from antigen sequences.
- The Synthetic Minority Oversampling Technique (SMOTE) was employed to mitigate class imbalance issues.
- A hybrid DL-TCNN model, combining 1D-CNN and TCN with causal convolutions and dilations, was developed and trained.
Main Results:
- The DL-TCNN model demonstrated high performance on training, validation, and testing datasets.
- Achieved 94.44% accuracy and 0.989 AUC on the training set.
- Reported 85.10% accuracy and 0.855 AUC on the testing set, outperforming existing CBCE prediction methods.
Conclusions:
- The proposed DL-TCNN framework represents a significant advancement in computational CBCE prediction.
- The model's superior performance highlights the potential of deep learning, particularly TCN architectures, in immunoinformatics.
- This approach offers a more accurate and efficient tool for applications in vaccine design and therapeutic development.
Related Concept Videos
B Cell Activation and Differentiation
1.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.8K
Cells of the Adaptive Immune Response
1.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
1.0K
Hybridoma Technology
14.9K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.9K

